On February 13, 2023, Shinva Medical Instrument Co., Ltd. completed the transaction. The company issued 54,900,098 shares at an issue price of CNY 23.38 for gross proceeds of CNY 1,278,074,281. The transaction included participation from Shandong Yiyang Health Industry Development Group Co., Ltd for 17,964,071 shares for CNY 419,999,979.98, Taikang Life Insurance LLC - Investment-Linked Multi-Strategy Preferred Investment Account for 4,277,159 shares for CNY 99,999,977.42,Caitong Fund Management Co., Ltd. for 2,707,442 shares for CNY 63,299,993.96, Jinan Gangtong No.

1 Investment Partnership Enterprise (Limited Partnership) for 2,566,295 shares for proceeds of CNY 59,999,977.10, E Fund Management Co., Ltd. for 2,566,295 shares for CNY 59,999,977.10, JIC Investment Co. Ltd., for 2,566,295 shares for CNY 59,999,977.10, Nuode Asset Management Co., Ltd. for 2,544,910 shares for proceeds of CNY 59,499,995.80, JPMorgan Chase Bank, National Association for 1,924,721 shares for CNY 44,999,976.98, Sunshine Asset Management Corporation Limited - Active Configure No. 2 Asset Management Product for 1,753,635 shares for proceeds of CNY 40,999,986.30, Chuhou New Energy Private Equity Securities Investment Fund for 1,710,863 shares for CNY 39,999,976.94, Taikang Life Insurance LLC - Universal - Personal Universal Product (D) for 1,710,863 shares for CNY 39,999,976.94, Taikang Life Insurance LLC - Universal - Personal Insurance Universal Product for 1,625,320 shares for CNY 37,999,981.60, Chuhou Yuanhang Special No.

1 Private Equity Securities Investment Fund for 1,283,147 shares for CNY 29,999,976.86